ABOS
Acumen Pharmaceuticals Inc.
$1.36
+$0.05(+3.82%)
41
Overall
--
Value
41
Tech
--
Quality
Market Cap
$88.44M
Volume
93.86K
52W Range
$0.86 - $3.36
Target Price
$7.80
EPS Estimates Overview
| Current Quarter | $-0.57 | Next Quarter | $-0.63 |
| Current Year | $-2.39 | Next Year | $-1.62 |
| QoQ Growth | -10.5% | YoY Growth | +32.2% |
| 3Y EPS CAGR | +23.6% | Target Price | $7.80 |
| Consensus | Buy | Upside | +473.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABOS | $1.36 | +3.8% | 93.86K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Acumen Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW